New vistas in Parkinson's disease. Proceedings of the International Symposium on Parkinson's Disease. Vienna, Austria, November 1-5, 1985.

T. Caraceni

Abstract:

What problem does this paper attempt to address?

Targeting Ferroptosis in Breast Cancer

Zhaoqing Li,Feng Cao,Cong Chen,Yulu Zhou,Dongyan Hu,Jingjing Yang,Yongxia Chen,Wenying Zhuo,Misha Mao,Xun Zhang,Ling Xu,Linbo Wang,Jichun Zhou

DOI: https://doi.org/10.1186/s40364-020-00230-3

2020-01-01

Biomarker Research

Abstract:Ferroptosis is a recently discovered distinct type of regulated cell death caused by the accumulation of lipid-based ROS. Metabolism and expression of specific genes affect the occurrence of ferroptosis, making it a promising therapeutic target to manage cancer. Here, we describe the current status of ferroptosis studies in breast cancer and trace the key regulators of ferroptosis back to previous studies. We also compare ferroptosis to common regulated cell death patterns and discuss the sensitivity to ferroptosis in different subtypes of breast cancer. We propose that viewing ferroptosis-related studies from a historical angle will accelerate the development of ferroptosis-based biomarkers and therapeutic strategies in breast cancer.
Ferroptosis and its emerging role in tumor

Xiaoxuan Wang,Zicheng Liu,Lijuan Ma,Haijie Yu

DOI: https://doi.org/10.52601/bpr.2021.210010

2021-08-31

Abstract:Ferroptosis is a novel form of programmed cell death characterized by iron-dependent lipid peroxidation accumulation. It is morphologically, biochemically, and genetically distinct from other known cell death, such as apoptosis, necrosis, and pyroptosis. Its regulatory mechanisms include iron metabolism, fatty acid metabolism, mitochondrial respiration, and antioxidative systems eliminating lipid peroxidation, such as glutathione synthesis, selenium-dependent glutathione peroxidase 4, and ubiquinone. The disruption of cellular redox systems causes damage to the cellular membrane leading to ferroptotic cell death. Recent studies have shown that numerous pathological diseases, like tumors, neurodegenerative disorders, and ischemia-reperfusion injury are associated with ferroptosis. As such, pharmacological regulation of ferroptosis either by activation or by suppression will provide a vast potential for treatments of relevant diseases. This review will discuss the advanced progress in ferroptosis and its regulatory mechanisms from both the antioxidative and oxidative sides. In addition, the roles of ferroptosis in various tumorigenesis, development, and therapeutic strategies will be addressed, particularly to chemotherapy and immunotherapy, as well as the discoveries from Traditional Chinese Medicine. This review will lead us to have a comprehensive understanding of the future exploration of ferroptosis and cancer therapy.
Ferroptosis: a New Promising Target for Hepatocellular Carcinoma Therapy

Qiaoping Xu,Lanqi Ren,Ning Ren,Yibei Yang,Junjie Pan,Yu Zheng,Gang Wang

DOI: https://doi.org/10.1007/s11010-023-04893-y

IF: 3.842

2023-01-01

Molecular and Cellular Biochemistry

Abstract:Hepatocellular carcinoma (HCC) is the sixed most common malignant tumor in the world. The study for HCC is mired in the predicament confronted with the difficulty of early diagnosis and high drug resistance, the survival rate of patients with HCC being low. Ferroptosis, an iron-dependent cell death, has been discovered in recent years as a cell death means with tremendous potential to fight against cancer. The in-depth researches for iron metabolism, lipid peroxidation and dysregulation of antioxidant defense have brought about tangible progress in the firmament of ferroptosis with more and more results showing close connections between ferroptosis and HCC. The potential role of ferroptosis has been widely used in chemotherapy, immunotherapy, radiotherapy, and nanotherapy, with the development of various new drugs significantly improving the prognosis of patients. Based on the characteristics and mechanisms of ferroptosis, this article further focuses on the main signaling pathways and promising treatments of HCC, envisioning that existing problems in regard with ferroptosis and HCC could be grappled with in the foreseeable future.
Advances in ferroptosis of cancer therapy

Ying Dong,Chaojie Xu,Jinli Guo,Yuchen Liu

DOI: https://doi.org/10.1515/oncologie-2023-0513

2024-01-01

ONCOLOGIE

Abstract:Abstract Ferroptosis is an iron-dependent mode of programmed cell death characterized by Reactive Oxygen Species (ROS) accumulation lipid peroxidation and glutathione depletion. It is a novel form of cell death different from apoptosis and necrosis. Because of its unique mode of cell death, it has attracted a large number of research reports from the oncology community. Changes in iron ions and accumulation of lipid peroxides have confirmed the correlation between ferroptosis and tumors, and thus ferroptosis can be considered to have a great oncological therapeutic potential. This paper brings to light the significance of metabolic pathways and key genes like System Xc-/Glutathione Peroxidase 4 (GPX4), Membrane-bound O-acyltransferases 1 (MBOAT1) and Membrane-bound O-acyltransferases 2 (MBOAT2) in modulating ferroptosis in cancer cells. The susceptibility of cancer cells to ferroptosis, influenced by their high levels of reactive oxygen species and specific mutation profiles, is analyzed, suggesting new avenues for enhancing the effectiveness of established cancer treatments. In this review, we address the current understanding of ferroptosis induction and ferroptosis defense mechanisms, briefly describe the role and mechanisms of ferroptosis in tumor suppression, and discuss therapeutic strategies for targeting ferroptosis caused by tumors.

oncology
Emerging mechanisms and targeted therapy of ferroptosis in cancer

Haiyan Wang,Yan Cheng,Chao Mao,Shuang Liu,Desheng Xiao,Jun Huang,Yongguang Tao

DOI: https://doi.org/10.1016/j.ymthe.2021.03.022

IF: 12.91

2021-07-01

Molecular Therapy

Abstract:<p>Ferroptosis is an iron- and lipid ROS-dependent form of programmed cell death that is distinct from other forms of regulatory cell death at the morphological, biological and genetic levels. Emerging evidence suggests critical roles for ferroptosis in cell metabolism, the redox status and various diseases, such as cancers, nervous system diseases, and ischemia-reperfusion injury, with ferroptosis-related proteins. Ferroptosis is inhibited in diverse cancer types and functions as a dynamic tumor suppressor in cancer development, indicating that the regulation of ferroptosis can be utilized as an interventional target for tumor treatment. Small molecules and nanomaterials that reprogram cancer cells to undergo ferroptosis are considered effective drugs for cancer therapy. Here, we systematically summarize the molecular basis of ferroptosis, the suppressive effect of ferroptosis on tumors, the effect of ferroptosis on cellular metabolism and the tumor microenvironment (TME), and ferroptosis-inducing agents for tumor therapeutics. An understanding of the latest progress in ferroptosis could provide references for proposing new potential targets for the treatment of cancers.</p>

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
A note on cancer and possible relationships to submolecular biology.

S. Reslova-Vasilukova,R. J. Williams

DOI: https://doi.org/10.1002/9780470720493.CH3

Abstract:
Broadening horizons: the multifaceted role of ferroptosis in breast cancer

Anqi Ge,Wang Xiang,Yan Li,Da Zhao,Junpeng Chen,Pawan Daga,Charles C. Dai,Kailin Yang,Yexing Yan,Moujia Hao,Bolin Zhang,Wei Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1455741

IF: 7.3

2024-11-28

Frontiers in Immunology

Abstract:Breast cancer poses a serious threat to women's health globally. Current radiotherapy and chemotherapy regimens can induce drug-resistance effects in cancer tissues, such as anti-apoptosis, anti-pyroptosis, and anti-necroptosis, leading to poor clinical outcomes in the treatment of breast cancer. Ferroptosis is a novel programmed cell death modality characterized by iron overload, excessive generation of reactive oxygen species, and membrane lipid peroxidation. The occurrence of ferroptosis results from the imbalance between intracellular peroxidation mechanisms (executive system) and antioxidant mechanisms (defensive system), specifically involving iron metabolism pathways, amino acid metabolism pathways, and lipid metabolism pathways. In recent years, it has been found that ferroptosis is associated with the progression of various diseases, including tumors, hypertension, diabetes, and Alzheimer's disease. Studies have confirmed that triggering ferroptosis in breast cancer cells can significantly inhibit cancer cell proliferation and invasion, and improve cancer cell sensitivity to radiotherapy and chemotherapy, making induction of ferroptosis a potential strategy for the treatment of breast cancer. This paper reviews the development of the concept of ferroptosis, the mechanisms of ferroptosis (including signaling pathways such as GSH-GPX4, FSP1-CoQ1, DHODH-CoQ10, and GCH1-BH4) in breast cancer disease, the latest research progress, and summarizes the research on ferroptosis in breast cancer disease within the framework of metabolism, reactive oxygen biology, and iron biology. The key regulatory factors and mechanisms of ferroptosis in breast cancer disease, as well as important concepts and significant open questions in the field of ferroptosis and related natural compounds, are introduced. It is hoped that future research will make further breakthroughs in the regulatory mechanisms of ferroptosis and the use of ferroptosis in treating breast cancer cells. Meanwhile, natural compounds may also become a new direction for potential drug development targeting ferroptosis in breast cancer treatment. This provides a theoretical basis and opens up a new pathway for research and the development of drugs for the prevention and treatment of breast cancer.

immunology
Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Zhenyu Nie,Mei Chen,Yuanhui Gao,Denggao Huang,Hui Cao,Yanling Peng,Na Guo,Fei Wang,Shufang Zhang

DOI: https://doi.org/10.3389/fphar.2022.879317

IF: 5.6

2022-05-21

Frontiers in Pharmacology

Abstract:Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics are commonly used to evaluate the conditions of various diseases especially in tumors. Accumulating evidence supports that ferroptosis can regulate tumor development, metastasis, and therapeutic responses. Considering to the important role of chemotherapy in tumor treatment, drug resistance has become the most serious challenge. Revealing the molecular mechanism of ferroptosis is expected to solve tumor drug resistance and find new therapies to treat cancers. In this review, we discuss the relationship between ferroptosis and tumor drug resistance, summarize the abnormal ferroptosis in tissues of different cancer types and current research progress and challenges in overcoming treatment resistance, and explore the concept of targeting ferroptosis to improve tumor treatment outcomes.

pharmacology & pharmacy
Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects

Shijing Yu,Lingwu Tong,Jiangwen Shen,Chenglei Li,Yongshan Hu,Keke Feng,Jingwei Shao

DOI: https://doi.org/10.1016/j.ejmech.2024.116290

IF: 7.088

2024-04-01

European Journal of Medicinal Chemistry

Abstract:The existing therapies for cancer are not remote satisfactory due to drug-resistance in tumors that are malignant. There is a pressing necessity to take a step forward to develop innovative therapies that can complement current ones. Multiple investigations have demonstrated that ferroptosis therapy, a non-apoptotic modality of programmed cell death, has tremendous potential in face of multiple crucial events, such as drug resistance and toxicity in aggressive malignancies. Recently, ferroptosis at the crosswalk of chemotherapy, materials science, immunotherapy, tumor microenvironment, and bionanotechnology has been presented to elucidate its therapeutic feasibility. Given the burgeoning progression of ferroptosis-based nanomedicine, the newest advancements in this field at the confluence of ferroptosis-inducers, nanotherapeutics, along with tumor microenvironment are given an overview. Here, the signaling pathways of ferroptosis-related were first talked about briefly. The emphasis discussion was placed on the pharmacological mechanisms and the nanodrugs design of ferroptosis inducing agents based on multiple distinct metabolism pathways. Additionally, a comprehensive overview of the action mechanisms by which the tumor microenvironment influences ferroptosis was elaborately descripted. Finally, some limitations of current researches and future research directions were also deliberately discussed to provide details about therapeutic avenues for ferroptosis-related diseases along with the design of anti-drugs.

chemistry, medicinal
Ferroptosis as a potential target for cancer therapy

Zhen Chen,Weilong Wang,Siti Razila Abdul Razak,Tao Han,Nor Hazwani Ahmad,Xiumin Li

DOI: https://doi.org/10.1038/s41419-023-05930-w

2023-07-25

Cell Death and Disease

Abstract:Ferroptosis is a recently discovered essential type of cell death that is mainly characterized by iron overload and lipid peroxidation. Emerging evidence suggests that ferroptosis is a double-edged sword in human cancer. However, the precise underlying molecular mechanisms and their differential roles in tumorigenesis are unclear. Therefore, in this review, we summarize and briefly present the key pathways of ferroptosis, paying special attention to the regulation of ferroptosis as well as its dual role as an oncogenic and as a tumor suppressor event in various human cancers. Moreover, multiple pharmacological ferroptosis activators are summarized, and the prospect of targeting ferroptosis in cancer therapy is further elucidated.

cell biology
Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer

Hong-Tao Wang,Jie Ju,Shao-Cong Wang,Yu-Hui Zhang,Cui-Yun Liu,Tao Wang,Xue Yu,Fei Wang,Xue-Ru Cheng,Kun Wang,Zhao-Yang Chen

DOI: https://doi.org/10.3389/fonc.2022.812534

IF: 4.7

2022-02-25

Frontiers in Oncology

Abstract:Ferroptosis is a new form of programmed cell death (PCD) characterized by an excess iron accumulation and subsequent unbalanced redox states. Ferroptosis is different from the already reported PCD and has unique morphological features and biochemical processes. Ferroptosis was first elaborated by Brent R. Stockwell’s lab in 2012, in which small molecules erastin and RSL-3 induce PCD in Ras mutant cell lines. Ferroptosis involves various physiological processes and occurrence of disease and especially shows strong potential in cancer treatment. Development of small molecule compounds based on Stockwell’s research was found to kill cancer cells, and some FDA-approved drugs were discovered to result in ferroptosis of cancer cells. Radiotherapy and checkpoint therapy have been widely used as a treatment for many types of cancer. Recently, some papers have reported that chemotherapy, radiotherapy, and checkpoint therapy induce ferroptosis of cancer cells, which provides new strategies for cancer treatment. Nevertheless, the limitless proliferation of tumor cells and the lack of cell death mechanisms are important reasons for drug resistance for tumor therapy. Therefore, we reviewed the molecular mechanism of ferroptosis and sensitivity to ferroptosis of different cancer cells and tumor treatment strategy.

oncology
Recent advances of ferroptosis in tumor: From biological function to clinical application

Shunfeng Hu,Yurou Chu,Xiangxiang Zhou,Xin Wang

DOI: https://doi.org/10.1016/j.biopha.2023.115419

Abstract:Ferroptosis is a recently recognized form of cell death with distinct features in terms of morphology, biochemistry, and molecular mechanisms. Unlike other types of cell death, ferroptosis is characterized by iron dependence, reactive oxygen species accumulation and lipid peroxidation. Recent studies have demonstrated that selective autophagy plays a vital role in the induction of ferroptosis, including ferritinophagy, lipophagy, clockophagy, and chaperone-mediated autophagy. Emerging evidence has indicated the involvement of ferroptosis in tumorigenesis through regulating various biological processes, including tumor growth, metastasis, stemness, drug resistance, and recurrence. Clinical and preclinical studies have found that novel therapies targeting ferroptosis exert great potential in the treatment of tumors. This review provides a comprehensive overview of the molecular mechanisms in ferroptosis, especially in autophagy-driven ferroptosis, discusses the recent advances in the biological roles of ferroptosis in tumorigenesis, and highlights the application of novel ferroptosis-targeted therapies in the clinical treatment of tumors.
The Mechanism of Ferroptosis and Applications in Tumor Treatment

Xinyue Lin,Jieyi Ping,Yi Wen,Yan Wu

DOI: https://doi.org/10.3389/fphar.2020.01061

IF: 5.6

2020-07-22

Frontiers in Pharmacology

Abstract:Iron-dependent ferroptosis is a new form of cell death in recent years, which is driven by lipid peroxidation. The lethal lipid accumulation caused by glutathione depletion or inactivation of glutathione peroxidase 4 (GPX4) is characteristic of the ferroptosis process. In recent years, with the in-depth study of ferroptosis, various types of diseases have been reported to be related to ferroptosis. In other words, ferroptosis, which has attracted widespread attention in the fields of biochemistry, oncology, and especially materials science, can undoubtedly provide a new way for patients. This review introduces the relevant mechanisms of ferroptosis, the relationship between ferroptosis and various cancers, as well as the application of ferroptosis in tumor treatment. We also sorted out the genes and drugs that regulate ferroptosis. Moreover, small molecule compound-induced ferroptosis has a strong inhibitory effect on tumor growth in a drug-resistant environment, which can enhance the sensitivity of chemotherapeutic drugs, suggesting that ferroptosis is very important in the treatment of tumor drug resistance, but the details are still unclear. How to use ferroptosis to fight cancer, and how to prevent drug-resistant tumor cells have become the focus and direction of research. At the end of the article, some existing problems related to ferroptosis are summarized for future research.

pharmacology & pharmacy
Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Zongchao Yu,Zhongcheng Mo,Yuan Qiu,Hengzhe Lu,Biao Zheng,Longfei Liu

DOI: https://doi.org/10.2174/0113892010276664231228124157

2024-01-26

Current Pharmaceutical Biotechnology

Abstract:Abstract: Ferroptosis is a newly discovered form of programmed cell death characterized by iron overload, ROS accumulation, and lipid peroxidation. It is distinguished by unique morphological, biochemical, and genetic features and stands apart from other known regulated cell death mechanisms. Studies have demonstrated a close association between ferroptosis and various cancers, including liver cancer, lung cancer, renal cell carcinoma, colorectal cancer, pancreatic cancer, and ovarian cancer. Inducing ferroptosis has shown promising results in inhibiting tumor growth and reversing tumor progression. However, the challenge lies in regulating ferroptosis in vivo due to the scarcity of potent compounds that can activate it. Integrating emerging biomedical discoveries and technological innovations with conventional therapies is imperative. Notably, considerable progress has been made in cancer treatment by leveraging immunotherapy and nanotechnology to trigger ferroptosis. This review explores the relationship between ferroptosis and emerging immunotherapies and nanotechnologies, along with their potential underlying mechanisms, offering valuable insights for developing novel cancer treatment strategies.

pharmacology & pharmacy,biochemistry & molecular biology
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Chen Zhang,Xinyin Liu,Shidai Jin,Yi Chen,Renhua Guo

DOI: https://doi.org/10.1186/s12943-022-01530-y

IF: 37.3

2022-02-12

Molecular Cancer

Abstract:Abstract Ferroptosis is an intracellular iron-dependent form of cell death that is distinct from apoptosis, necrosis, and autophagy. Extensive studies suggest that ferroptosis plays a pivotal role in tumor suppression, thus providing new opportunities for cancer therapy. The development of resistance to cancer therapy remains a major challenge. A number of preclinical and clinical studies have focused on overcoming drug resistance. Intriguingly, ferroptosis has been correlated with cancer therapy resistance, and inducing ferroptosis has been demonstrated to reverse drug resistance. Herein, we provide a detailed description of the mechanisms of ferroptosis and the therapeutic role of regulating ferroptosis in reversing the resistance of cancer to common therapies, such as chemotherapy, targeted therapy and immunotherapy. We discuss the prospect and challenge of regulating ferroptosis as a therapeutic strategy for reversing cancer therapy resistance and expect that our review could provide some references for further studies.

oncology,biochemistry & molecular biology
Ferroptosis in Cancer Treatment: Another Way to Rome

Yinan Wu,Chengcheng Yu,Meng Luo,Chen Cen,Jili Qiu,Suzhan Zhang,Kaimin Hu

DOI: https://doi.org/10.3389/fonc.2020.571127

IF: 4.7

2020-09-25

Frontiers in Oncology

Abstract:Ferroptosis is a newly described type of programmed cell death and intensively related to both maintaining homeostasis and the development of diseases, especially cancers. Inducing ferroptosis leads to mitochondrial dysfunction and toxic lipid peroxidation in cells, which plays a pivotal role in suppressing cancer growth and progression. Here, we reviewed the existing studies about the molecular mechanisms of ferroptosis involved in different antitumor treatments, such as chemotherapy, targeted therapy, radiotherapy, and immunotherapy. We focused in particular on the distinct combinatorial therapeutic effects such as the synergistic sensitization effect and the drug-resistance reversal achieved when using ferroptosis inducers with conventional cancer therapy. Finally, we discussed the challenges and opportunities in clinical applications of ferroptosis. The application of nanotechnolgy and other novel technologies may provide a new direction in ferroptosis-driven cancer therapies.

oncology
Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation

Siyue Liu,Ming Yue,Yukang Lu,Ying Wang,Shiwen Luo,Xiaoliu Liu,Jue Jiang

DOI: https://doi.org/10.1007/s10495-023-01891-9

2023-09-26

APOPTOSIS

Abstract:In recent years, colorectal cancer incidence and mortality have increased significantly due to poor lifestyle choices. Despite the development of various treatments, their effectiveness against advanced/metastatic colorectal cancer remains unsatisfactory due to drug resistance. However, ferroptosis, a novel iron-dependent cell death process induced by lipid peroxidation and elevated reactive oxygen species (ROS) levels along with reduced activity of the glutathione peroxidase 4 (GPX4) antioxidant enzyme system, shows promise as a therapeutic target for colorectal cancer. This review aims to delve into the regulatory mechanisms of ferroptosis in colorectal cancer, providing valuable insights into potential therapeutic approaches. By targeting ferroptosis, new avenues can be explored for innovative therapies to combat colorectal cancer more effectively. In addition, understanding the molecular pathways involved in ferroptosis may help identify biomarkers for prognosis and treatment response, paving the way for personalized medicine approaches. Furthermore, exploring the interplay between ferroptosis and other cellular processes can uncover combination therapies that enhance treatment efficacy. Investigating the tumor microenvironment’s role in regulating ferroptosis may offer strategies to sensitize cancer cells to cell death induction, leading to improved outcomes. Overall, ferroptosis presents a promising avenue for advancing the treatment of colorectal cancer and improving patient outcomes.

cell biology,biochemistry & molecular biology
Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities

Guang Lei,Boyi Gan

DOI: https://doi.org/10.1158/0008-5472.can-23-4042

IF: 11.2

2024-04-02

Cancer Research

Abstract:Conventional cancer therapies typically aim to eliminate tumor cells by inducing cell death. The emergence of resistance to these standard treatments has spurred a shift in focus toward exploring alternative cell death pathways beyond apoptosis. Ferroptosis—an iron-dependent regulated cell death triggered by lipid peroxide accumulation—has gained prominence in cancer research in recent years. Ferroptosis-inducing therapies hold promise for overcoming resistance encountered with conventional treatments. However, challenges, including the lack of distinctive ferroptosis markers and the intricate role of ferroptosis within the tumor microenvironment, currently hinder the clinical translation of these therapies. This perspective article critically outlines these hurdles and highlights unexplored opportunities in ferroptosis research, aiming to refine its therapeutic utilization in combating cancer.

oncology
Ferroptosis-Inducing Nanomedicine for Cancer Therapy

Yang Wang,Tianfu Liu,Xiang Li,Hui Sheng,Xiaowen Ma,Liang Hao

DOI: https://doi.org/10.3389/fphar.2021.735965

IF: 5.6

2021-12-20

Frontiers in Pharmacology

Abstract:Ferroptosis, a new iron- and reactive oxygen species–dependent form of regulated cell death, has attracted much attention in the therapy of various types of tumors. With the development of nanomaterials, more and more evidence shows the potential of ferroptosis combined with nanomaterials for cancer therapy. Recently, there has been much effort to develop ferroptosis-inducing nanomedicine, specially combined with the conventional or emerging therapy. Therefore, it is necessary to outline the previous work on ferroptosis-inducing nanomedicine and clarify directions for improvement and application to cancer therapy in the future. In this review, we will comprehensively focus on the strategies of cancer therapy based on ferroptosis-inducing nanomedicine currently, elaborate on the design ideas of synthesis, analyze the advantages and limitations, and finally look forward to the future perspective on the emerging field.

pharmacology & pharmacy

New vistas in Parkinson's disease. Proceedings of the International Symposium on Parkinson's Disease. Vienna, Austria, November 1-5, 1985.

Targeting Ferroptosis in Breast Cancer

Ferroptosis and its emerging role in tumor

Ferroptosis: a New Promising Target for Hepatocellular Carcinoma Therapy

Advances in ferroptosis of cancer therapy

Emerging mechanisms and targeted therapy of ferroptosis in cancer

A note on cancer and possible relationships to submolecular biology.

Broadening horizons: the multifaceted role of ferroptosis in breast cancer

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects

Ferroptosis as a potential target for cancer therapy

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer

Recent advances of ferroptosis in tumor: From biological function to clinical application

The Mechanism of Ferroptosis and Applications in Tumor Treatment

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Ferroptosis in Cancer Treatment: Another Way to Rome

Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation

Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities

Ferroptosis-Inducing Nanomedicine for Cancer Therapy